Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Association of cancer center type with treatment patterns and overall survival for patients with sacral and spinal chordomas: an analysis of the National Cancer Database from 2004 to 2015.

Wright CH, Wright J, Cioffi G, Hdeib A, Kasliwal MK, Kruchko C, Barnholtz-Sloan JS, Sloan AE.

J Neurosurg Spine. 2019 Nov 1:1-10. doi: 10.3171/2019.7.SPINE19566. [Epub ahead of print]

PMID:
31675723
2.

Chordomas of the Skull Base, Mobile Spine, and Sacrum: An Epidemiologic Investigation of Presentation, Treatment, and Survival.

Zuckerman SL, Bilsky MH, Laufer I.

World Neurosurg. 2018 May;113:e618-e627. doi: 10.1016/j.wneu.2018.02.109. Epub 2018 Feb 25.

PMID:
29486315
3.

Sacral Insufficiency Fractures are Common After High-dose Radiation for Sacral Chordomas Treated With or Without Surgery.

Osler P, Bredella MA, Hess KA, Janssen SJ, Park CJ, Chen YL, DeLaney TF, Hornicek FJ, Schwab JH.

Clin Orthop Relat Res. 2016 Mar;474(3):766-72. doi: 10.1007/s11999-015-4566-5. Epub 2015 Sep 23.

4.

Long-term outcomes of high-dose single-fraction radiosurgery for chordomas of the spine and sacrum.

Jin CJ, Berry-Candelario J, Reiner AS, Laufer I, Higginson DS, Schmitt AM, Lis E, Barzilai O, Boland P, Yamada Y, Bilsky MH.

J Neurosurg Spine. 2019 Oct 18:1-10. doi: 10.3171/2019.7.SPINE19515. [Epub ahead of print]

PMID:
31628294
5.

Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.

Mukherjee D, Chaichana KL, Gokaslan ZL, Aaronson O, Cheng JS, McGirt MJ.

J Neurosurg Spine. 2011 Feb;14(2):143-50. doi: 10.3171/2010.10.SPINE10189. Epub 2010 Dec 24.

PMID:
21184634
6.

Type and case volume of health care facility influences survival and surgery selection in cases with early-stage non-small cell lung cancer.

Wang S, Lai S, von Itzstein MS, Yang L, Yang DM, Zhan X, Xiao G, Halm EA, Gerber DE, Xie Y.

Cancer. 2019 Dec 1;125(23):4252-4259. doi: 10.1002/cncr.32377. Epub 2019 Sep 10.

PMID:
31503336
7.

Is Treatment at a High-Volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?

Malik AT, Alexander JH, Khan SN, Scharschmidt TJ.

Clin Orthop Relat Res. 2019 Oct 30. doi: 10.1097/CORR.0000000000001034. [Epub ahead of print]

PMID:
31714413
8.

Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.

Pan Y, Lu L, Chen J, Zhong Y, Dai Z.

J Orthop Surg Res. 2018 Apr 6;13(1):76. doi: 10.1186/s13018-018-0784-3.

9.

Chordoma of the mobile spine and sacrum: clinical management and prognosis.

D'Amore T, Boyce B, Mesfin A.

J Spine Surg. 2018 Sep;4(3):546-552. doi: 10.21037/jss.2018.07.09.

10.

Disease outcomes for skull base and spinal chordomas: a single center experience.

Ahmed R, Sheybani A, Menezes AH, Buatti JM, Hitchon PW.

Clin Neurol Neurosurg. 2015 Mar;130:67-73. doi: 10.1016/j.clineuro.2014.12.015. Epub 2014 Dec 29.

PMID:
25590662
11.

Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients.

Hsieh PC, Xu R, Sciubba DM, McGirt MJ, Nelson C, Witham TF, Wolinksy JP, Gokaslan ZL.

Spine (Phila Pa 1976). 2009 Sep 15;34(20):2233-9. doi: 10.1097/BRS.0b013e3181b61b90.

PMID:
19752710
12.

What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?

Ji T, Guo W, Yang R, Tang X, Wang Y, Huang L.

Clin Orthop Relat Res. 2017 Mar;475(3):620-630. doi: 10.1007/s11999-016-4773-8.

13.

High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors.

Rotondo RL, Folkert W, Liebsch NJ, Chen YL, Pedlow FX, Schwab JH, Rosenberg AE, Nielsen GP, Szymonifka J, Ferreira AE, Hornicek FJ, DeLaney TF.

J Neurosurg Spine. 2015 Dec;23(6):788-97. doi: 10.3171/2015.3.SPINE14716. Epub 2015 Sep 4.

PMID:
26340383
14.

The clinical outcomes for chordomas in the cranial base and spine: A single center experience.

Zhou Y, Hu B, Wu Z, Cheng H, Dai M, Zhang B.

Medicine (Baltimore). 2019 Jun;98(23):e15980. doi: 10.1097/MD.0000000000015980.

15.

Comparison of facility type outcomes for oral cavity cancer: Analysis of the national cancer database.

Rubin SJ, Cohen MB, Kirke DN, Qureshi MM, Truong MT, Jalisi S.

Laryngoscope. 2017 Nov;127(11):2551-2557. doi: 10.1002/lary.26632. Epub 2017 Jul 3.

PMID:
28671267
16.

Sacral chordoma: a clinical review of 101 cases with 30-year experience in a single institution.

van Wulfften Palthe ODR, Tromp I, Ferreira A, Fiore A, Bramer JAM, van Dijk NC, DeLaney TF, Schwab JH, Hornicek FJ.

Spine J. 2019 May;19(5):869-879. doi: 10.1016/j.spinee.2018.11.002. Epub 2018 Nov 14.

PMID:
30445184
17.

Definitive high-dose photon/proton radiotherapy for unresected mobile spine and sacral chordomas.

Chen YL, Liebsch N, Kobayashi W, Goldberg S, Kirsch D, Calkins G, Childs S, Schwab J, Hornicek F, DeLaney T.

Spine (Phila Pa 1976). 2013 Jul 1;38(15):E930-6. doi: 10.1097/BRS.0b013e318296e7d7.

PMID:
23609202
18.

Evaluating the Role of Adjuvant Radiotherapy in the Management of Sacral and Vertebral Chordoma: Results from a National Database.

Yolcu Y, Wahood W, Alvi MA, Kerezoudis P, Okuno SH, Foote RL, Bydon M.

World Neurosurg. 2019 Jul;127:e1137-e1144. doi: 10.1016/j.wneu.2019.04.070. Epub 2019 Apr 14.

PMID:
30995559
19.

Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database.

Gokaslan ZL, Zadnik PL, Sciubba DM, Germscheid N, Goodwin CR, Wolinsky JP, Bettegowda C, Groves ML, Luzzati A, Rhines LD, Fisher CG, Varga PP, Dekutoski MB, Clarke MJ, Fehlings MG, Quraishi NA, Chou D, Reynolds JJ, Williams RP, Kawahara N, Boriani S.

J Neurosurg Spine. 2016 Apr;24(4):644-51. doi: 10.3171/2015.7.SPINE15201. Epub 2015 Dec 18.

20.

Sacral chordoma: 40-year experience at a major cancer center.

York JE, Kaczaraj A, Abi-Said D, Fuller GN, Skibber JM, Janjan NA, Gokaslan ZL.

Neurosurgery. 1999 Jan;44(1):74-9; discussion 79-80.

PMID:
9894966

Supplemental Content

Support Center